OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELL

OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELL

PHARMACEUTICAL PREPARATIONS CONTAINING A CARRIER FOR THE IN VIVO DELIVERY TO HEPATOCYTES OF OLIGONUCLEOTIDES THAT CAN ALTER A GENE OF THE HEPATOCYTE FOR THE PURPOSE OF TREATING GENETIC DEFECTS, METABOLIC DISORDERS, INFECTIOUS DISEASES AND NEOPLASTIC DISEASES